News

Marksans Pharma informs about board meeting intimation

Marksans Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 08/07/2022, to consider and approve the proposal for buyback of fully paid up equity shares of the Company up to such amount of the aggregate of Company's paid up equity share capital and free reserves as the Board may decide in accordance with the provisions of Section 68, 69 and 70 of the Companies Act, 2013 and the SEBI (Buyback of Securities) Regulations, 2018. It is further submitted that in terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company for the designated person(s) is already closed with effective from July 01, 2022 and will remain closed till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2022.
The above information is a part of company’s filings submitted to BSE.